Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls.

  • Read more about Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls.

Neuropsychological correlates of multiple sclerosis across the lifespan.

  • Read more about Neuropsychological correlates of multiple sclerosis across the lifespan.

Menarche increases relapse risk in pediatric multiple sclerosis.

  • Read more about Menarche increases relapse risk in pediatric multiple sclerosis.

Impact of parental multiple sclerosis on early childhood development: A retrospective cohort study.

  • Read more about Impact of parental multiple sclerosis on early childhood development: A retrospective cohort study.

Copy number variation in pediatric multiple sclerosis.

  • Read more about Copy number variation in pediatric multiple sclerosis.

Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis.

  • Read more about Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis.

EDSS variability before randomization may limit treatment discovery in primary progressive MS.

  • Read more about EDSS variability before randomization may limit treatment discovery in primary progressive MS.

Relapse severity and recovery in early pediatric multiple sclerosis.

  • Read more about Relapse severity and recovery in early pediatric multiple sclerosis.

Vitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis.

  • Read more about Vitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis.

Switching first-line disease-modifying therapy after failure: impact on the course of relapsing-remitting multiple sclerosis.

  • Read more about Switching first-line disease-modifying therapy after failure: impact on the course of relapsing-remitting multiple sclerosis.

Pagination

  • Previous page ‹‹
  • Page 4
  • Next page ››
Subscribe to Multiple sclerosis (Houndmills, Basingstoke, England)

Pediatrics Home

MAKE A GIFT

© 2026 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                   Accessibility  Privacy Policy  Terms of Use  A-Z Website List